Skip to main content

Advertisement

Figure 6 | Radiation Oncology

Figure 6

From: Evaluation of poly (ADP-ribose) polymerase inhibitor ABT-888 combined with radiotherapy and temozolomide in glioblastoma

Figure 6

Cell survival curves of MGMT-unmethylated LN18 (a) and T98G cells (b), and MGMT-methylated U87 (c) and U251 cells (d). Cells were treated with 5 μM ABT-888 for 5 h before being exposed to either 5 (c ,d) or 10 (a, b) μM TMZ for 2 h, including 1 h before and 1 h after irradiation. Symbols represent mean ± standard error of at least three independent experiments.

Back to article page